Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06604884
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-17
Brief Title:
NV PSR INSPIRE-A Pipeline Vantage Post Approval Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Neurovascular Product Surveillance Registry NV PSR INSPIRE Pipeline Vantage Embolization Device With Shield Technology Post Approval Study PAS
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the Pipeline Vantage Embolization Device with Shield Technology Post Approval Study PAS Pipeline Vantage PAS is to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms IA using the Pipeline Vantage Embolization Device with Shield Technology Pipeline Vantage Device in a post approval setting
Detailed Description:
The INSPIRE Pipeline Vantage Post Approval Study is a prospective multi-center single-arm clinical study to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms using the Pipeline Vantage Embolization Device with Shield Technology
This study is a sub-study to the Neurovascular Product Surveillance Registry NCT02988128
This study is a sub-study to the Neurovascular Product Surveillance Registry NCT02988128
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None